{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:31:04Z","timestamp":1778542264577,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jocn.2020.07.075","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T14:09:12Z","timestamp":1597846152000},"page":"152-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Impulse control disorders in chronic migraine with medication overuse after onabotulinumtoxinA: A single-center prospective cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"Florindo","family":"d'Onofrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"de Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Spitaleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Casucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Raimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jocn.2020.07.075_b0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10194-010-0282-4","article-title":"Migraine and psychiatric comorbidity: a review of clinical findings","volume":"12","author":"Antonaci","year":"2011","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpain.2014.10.002","article-title":"The associations between preexisting mental disorders and subsequent onset of chronic headaches: a worldwide epidemiologic perspective","volume":"16","author":"Bruffaerts","year":"2015","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.jocn.2020.07.075_b0015","first-page":"1","article-title":"Botulinum toxin: a lift for chronic migraines","volume":"29","author":"Sanassi","year":"2016","journal-title":"J Am Acad Phys Assist"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ane.12171","article-title":"OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program","volume":"129","author":"Aurora","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10194-019-1030-z","article-title":"Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study","volume":"20","author":"Stark","year":"2019","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10194-019-0976-1","article-title":"An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study","volume":"20","author":"Ahmed","year":"2019","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s10194-018-0918-3","article-title":"Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment","volume":"19","author":"Vikelis","year":"2018","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s10194-018-0840-8","article-title":"Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study","volume":"19","author":"Blumenfeld","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jocn.2020.07.075_b0050","doi-asserted-by":"crossref","unstructured":"Guerzoni S, Pellesi L, Baraldi C, Cainazzo MM, Negro A, Martelletti P, Pini LA. Long-term treatment benefits and prolonged efficacy of OnabotulinumtoxinA in patients affected by chronic migraine and medication overuse headache over 3\u2009years of Therapy. Front Neurol 2017;8:586.","DOI":"10.3389\/fneur.2017.00586"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-017-0723-4","article-title":"OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study","volume":"18","author":"Aydinlar","year":"2017","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jocn.2020.07.075_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","article-title":"Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial","volume":"52","author":"Finzi","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jocn.2020.07.075_b0065","doi-asserted-by":"crossref","unstructured":"Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 2011;51(9):1358\u201373.","DOI":"10.1111\/j.1526-4610.2011.01990.x"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s10194-018-0953-0","article-title":"Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study","volume":"20","author":"Young","year":"2019","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10194-018-0952-1","article-title":"Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study","volume":"20","author":"Young","year":"2019","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-018-0875-x","article-title":"Medication-overuse headache: a widely recognized entity amidst ongoing debate","volume":"19","author":"Vandenbussche","year":"2018","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2020.07.075_b0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10194-017-0830-2","article-title":"The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine","volume":"19","author":"Martelletti","year":"2018","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.jocn.2020.07.075_b0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","article-title":"Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety","volume":"90","author":"Blumenfeld","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2020.07.075_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/IJGM.S70456","article-title":"Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety","volume":"8","author":"Boudreau","year":"2015","journal-title":"Int J Gen Med"},{"issue":"8","key":"10.1016\/j.jocn.2020.07.075_b0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depressive disorder using botulinum toxin a: a 24-week randomized, double-blind, placebo-controlled study","volume":"75","author":"Magid","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2020.07.075_b0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s42399-020-00270-8","article-title":"Chronic migraine headaches: role of smoking and locus of control","volume":"2","author":"Lee","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"5","key":"10.1016\/j.jocn.2020.07.075_b0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10194-009-0136-0","article-title":"Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism","volume":"10","author":"Di Lorenzo","year":"2009","journal-title":"J Headache Pain"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820314442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820314442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:22:52Z","timestamp":1760822572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820314442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"alternative-id":["S0967586820314442"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.07.075","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impulse control disorders in chronic migraine with medication overuse after onabotulinumtoxinA: A single-center prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.07.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}